Cas No.: | 25526-93-6 |
Chemical Name: | 3'-Deoxy-3'-fluorothymidine |
Synonyms: | 3'-Deoxy-3'-fluorothymidine;3,-Deoxy-3,-fluoro Thymidine;3’-Deoxy-3’-fluoro Thymidine;3'-Fluoro-3'-deoxythymidine;Alovudine;1-(3'-Deoxy-3'-fluoro-b-D-pentofuranosyl)thymine;3'-Fluorodeoxythymidine;3'-Fluorothymidine;CL 184824;FLT;MIV 310;NSC 140025 |
SMILES: | CC1=CN(C(NC1=O)=O)[C@H]2C[C@H](F)[C@H](O2)CO |
Formula: | C10H13N2O4F |
M.Wt: | 244.21962 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | 3'-Fluoro-3'-deoxythymidine (Alovudine) is a marker of DNA synthesis that is less susceptible to inflammatory changes than 18F-Fluorodeoxyglucose (FDG) and thus is a better biomarker in pancreatic cancer[1]. |
References: | [1]. Challapalli A, et al. 3'-Deoxy-3'-18F-fluorothymidine positron emission tomography as an early predictor of disease progression in patients with advanced and metastatic pancreatic cancer. Eur J Nucl Med Mol Imaging. 2015 May;42(6):831-40. |